- Previous Close
91.71 - Open
0.00 - Bid 87.00 x --
- Ask 92.52 x --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 94.78 - Volume
0 - Avg. Volume
770 - Market Cap (intraday)
484.265B - Beta (5Y Monthly) 1.70
- PE Ratio (TTM)
16.80 - EPS (TTM)
5.47 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield 0.47 (0.51%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
www.hcahealthcare.com220,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: H1CA34.SA
Performance Overview: H1CA34.SA
Trailing total returns as of 6/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: H1CA34.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: H1CA34.SA
Valuation Measures
Market Cap
484.26B
Enterprise Value
706.95B
Trailing P/E
16.80
Forward P/E
16.34
PEG Ratio (5yr expected)
1.49
Price/Sales (ttm)
1.38
Price/Book (mrq)
--
Enterprise Value/Revenue
1.94
Enterprise Value/EBITDA
9.88
Financial Highlights
Profitability and Income Statement
Profit Margin
8.20%
Return on Assets (ttm)
11.12%
Return on Equity (ttm)
845.54%
Revenue (ttm)
66.72B
Net Income Avi to Common (ttm)
5.47B
Diluted EPS (ttm)
5.47
Balance Sheet and Cash Flow
Total Cash (mrq)
1.38B
Total Debt/Equity (mrq)
3,315.20%
Levered Free Cash Flow (ttm)
3.78B